Abbott Laboratories News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

19.05.23	Abbott Announces FDA Approval For TactiFlex Ablation Catheter (RTTNews)
19.05.23	Abbott Receives FDA Approval for TactiFlex™ Ablation Catheter for Treatment of Abnormal Heart Rhythm (PR Newswire)
18.05.23	Abbott Laboratories Says FDA Approves Assert-IQ Insertable Cardiac Monitor (RTTNews)
18.05.23	Abbott Receives FDA Clearance for Assert-IQ™ Insertable Cardiac Monitor to Help Doctors Monitor People's Heart Rhythms Long-Term (PR Newswire)
16.05.23	Abbott Says FDA Approves Spinal Cord Stimulation Devices To Treat Chronic Back Pain (RTTNews)
16.05.23	Abbott Receives FDA Approval for Its Spinal Cord Stimulation Systems to Treat Chronic Back Pain in People Who Have Limited Surgical Options (PR Newswire)
11.05.23	Abbott Announces New Partnerships and Programs to Advance its Diversity in Clinical Trials Initiative (PR Newswire)
27.04.23	Abbott Completes Acquisition of Cardiovascular Systems, Inc. (PR Newswire)
25.04.23	Cytek Biosciences Set to Join S&P SmallCap 600 (PR Newswire)
25.04.23	Abbott Announces Two New FDA Clearances For Life Support System (RTTNews)
25.04.23	Abbott's Life Support System Receives New FDA Clearances to Help Doctors Treat More Critically Ill Patients (PR Newswire)
20.04.23	Abbott and New Global Consortium Partnership Address Viral Outbreaks Caused by Climate Change (PR Newswire)
19.04.23	Abbott Laboratories Q1 Profit Decreases, but beats estimates (RTTNews)
19.04.23	Abbott Reports First-Quarter 2023 Results; Increases Outlook For Underlying Base Business (PR Newswire)
17.04.23	Abbott's FreeStyle Libre® Continuous Glucose Monitoring Systems Obtain Significantly Expanded Coverage for Medicare Beneficiaries (PR Newswire)
14.04.23	Abbott: FDA Clears Reader For FreeStyle Libre 3 Integrated Continuous Glucose Monitoring System (RTTNews)
14.04.23	FDA Clears Reader for Abbott's FreeStyle Libre® 3 System (PR Newswire)
29.03.23	Abbott Hosts Conference Call for First-Quarter Earnings (PR Newswire)
23.03.23	Don't Mess with Your 'Melon': Abbott and the Brain Injury Association of America Urge 'If You Hit Your Head, Get it Checked' in New Public Service Announcement (PR Newswire)
07.03.23	Abbott Receives FDA Clearance for First Commercially Available Lab-based Blood Test to Help Evaluate Concussion (PR Newswire)
06.03.23	Abbott: FDA Clears FreeStyle Libre 2, 3 Sensors For Integration With AID Systems (RTTNews)
06.03.23	U.S. FDA Clears Abbott's FreeStyle Libre® 2 and FreeStyle Libre® 3 Sensors for Integration with Automated Insulin Delivery Systems (PR Newswire)
06.03.23	Abbott: Data Show Long-Term Benefits Of MitraClip Device For Treating Secondary Mitral Regurgitation (RTTNews)
05.03.23	Late-Breaking Data from Landmark COAPT™ Trial Show Long-Term Benefits of Abbott's MitraClip™ Device (PR Newswire)
04.03.23	New Data Show Superiority of Abbott's TriClip™ Device Compared to Medical Therapy for Tricuspid Regurgitation (PR Newswire)
28.02.23	Late-Breaking Data Reinforce Benefits of Abbott's Minimally Invasive Heart Devices (PR Newswire)
17.02.23	Abbott Declares 397th Consecutive Quarterly Dividend (PR Newswire)
09.02.23	Abbott To Acquire Cardiovascular Systems In $890 Mln Deal (RTTNews)
09.02.23	Abbott to Acquire Cardiovascular Systems, Inc. (PR Newswire)
26.01.23	Abbott Says FDA Oks Proclaim XR Spinal Cord Stimulation System To Treat DPN (RTTNews)
26.01.23	FDA Approves Abbott's Spinal Cord Stimulation for People Living with Painful Diabetic Peripheral Neuropathy (PR Newswire)
25.01.23	Abbott Issues FY23 Earnings, Sales Growth View - Update (RTTNews)
25.01.23	Abbott Laboratories Q4 Profit Decreases, but beats estimates (RTTNews)
25.01.23	Abbott Reports Fourth-Quarter and Full-Year 2022 Results; Issues 2023 Financial Outlook (PR Newswire)
21.01.23	Abbott Reportedly Under Criminal Probe Over Baby Formula (RTTNews)
17.01.23	Abbott Says FDA Oks Navitor TAVI System To Treat Severe Aortic Stenosis (RTTNews)
17.01.23	Abbott Receives FDA Approval for Navitor™, a Next-Generation TAVI System Designed to Treat Aortic Stenosis (PR Newswire)
07.01.23	Abbott, Blood Centers of America Launch First-of-its-Kind Mixed Reality Experience for Use During Blood Donation (PR Newswire)
04.01.23	Abbott Hosts Conference Call for Fourth-Quarter Earnings (PR Newswire)
21.12.22	Abbott : FreeStyle Libre 3 Integrated With Automated Insulin Delivery System Mylife Loop In Germany (RTTNews)
21.12.22	Abbott's FreeStyle Libre® 3 Integrated with Automated Insulin Delivery System mylife™ Loop in Germany (PR Newswire)
20.12.22	Abbott to Present at J.P. Morgan Healthcare Conference (PR Newswire)
19.12.22	Abbott Launches the World's Smallest Implantable, Rechargeable Spinal Cord Stimulation System for Chronic Pain (PR Newswire)
13.12.22	Abbott and the Brain Injury Association of America launch Concussion Awareness Now coalition; team up with Rebel Wilson to raise awareness on seriousness of concussions (PR Newswire)
09.12.22	Abbott Increases Quarterly Dividend, Marking 51 Consecutive Years of Dividend Growth (PR Newswire)
17.11.22	Abbott Receives Three CES 2023 Innovation Awards for Advancements in Health Technology (PR Newswire)
31.10.22	ABT FINAL DEADLINE TODAY: ROSEN, A TOP RANKED LAW FIRM, Encourages Abbott Laboratories Investors to Secure Counsel Before Important October 31 Deadline in Securities Class Action - ABT (PR Newswire)
28.10.22	Abbott's FreeStyle Libre® is Named Best Medical Technology in Last 50 Years by the Galien Foundation (PR Newswire)
23.10.22	ABT APPROACHING DEADLINE: ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Abbott Laboratories Investors With Losses Over $100K to Secure Counsel Before Important October 31 Deadline in Securities Cl... (PR Newswire)
19.10.22	Abbott Laboratories Boosts FY22 Outlook - Update (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

19.11.24		Schwacher Handel: Dow Jones beendet den Dienstagshandel mit Verlusten
19.11.24		Gute Stimmung in New York: NASDAQ 100 letztendlich im Plus
19.11.24		Schwacher Handel: Dow Jones legt am Dienstagnachmittag den Rückwärtsgang ein
19.11.24		Gewinne in New York: NASDAQ 100 legt zu
19.11.24		Dow Jones-Handel aktuell: So entwickelt sich der Dow Jones aktuell
19.11.24		Angespannte Stimmung in Europa: STOXX 50 verliert schlussendlich
19.11.24		Schwache Performance in Europa: Euro STOXX 50 zeigt sich zum Handelsende schwächer

19.11.24

Schwacher Handel: Dow Jones beendet den Dienstagshandel mit Verlusten

19.11.24

Gute Stimmung in New York: NASDAQ 100 letztendlich im Plus

19.11.24

Schwacher Handel: Dow Jones legt am Dienstagnachmittag den Rückwärtsgang ein

19.11.24

Gewinne in New York: NASDAQ 100 legt zu

19.11.24

Dow Jones-Handel aktuell: So entwickelt sich der Dow Jones aktuell

19.11.24

Angespannte Stimmung in Europa: STOXX 50 verliert schlussendlich

19.11.24

Schwache Performance in Europa: Euro STOXX 50 zeigt sich zum Handelsende schwächer

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Givaudan	3’870.00	1.49 %	K V
Lonza Grp	513.60	1.14 %	K V
Swiss Re	125.25	0.20 %	K V
Holcim	88.46	0.11 %	K V
Kuehne+Nagel Int	210.40	0.00 %	K V
Logitech Intl	68.92	-1.20 %	K V
Part Grp Hldg	1’209.00	-1.47 %	K V
CieFinRichemont	118.90	-1.94 %	K V
Nestle	76.66	-1.94 %	K V
Sonova Hldg	300.40	-5.21 %	K V

Nachrichten zu Abbott Laboratories

Aktien Top/Flop

Abbott Laboratories Peer Group Nachrichten

Meistgelesene Nachrichten